NASDAQ •
Healthcare •
Biotechnology •
Quote as of 06/04/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,597.54 mln
Float32.75 mln
Earnings Date08/06/2026
Piotroski F-Score
2
/ 9
Weak
1-Year Forecast
101
Exceptional upside
Relative Strength
79
/ 100
Strongly outperforming
Debt / Equity
0.05
Debt-free
ROE
-36.87
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Disc Medicine is a clinical-stage company focused on developing new treatments for serious blood disorders. Founded in 2017 and based in Watertown, Massachusetts, the company is building a pipeline of medicines that target the biological processes controlling how red blood cells are made and how the body manages iron. Its leading drug candidates address conditions such as erythropoietic porphyrias, anemia linked to kidney disease and myelofibrosis, polycythemia vera, and anemia caused by inflammatory diseases.
